Concepedia

John M. Amatruda

JM

79

Publications

6.1K

Citations

47

H-Index

1971

Active since

Affiliations

University of Rochester(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Johns Hopkins University

University of Rochester Medical Center

Pennington Biomedical Research Center

John M. Amatruda is an author at University of Rochester specializing in medicine, physiology, and health sciences.

Top concepts

Publications per year

1971–2012

79

Publications

79

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen et al. · Diabetes Obesity and Metabolism · 2009 · 303 citations · Full text

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Itamar Raz, Yu Chen, Mei Wu et al. · Current Medical Research and Opinion · 2008 · 259 citations

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Juliana C.N. Chan, Russell Scott, Juan Camilo Arjona Ferreira et al. · Diabetes Obesity and Metabolism · 2008 · 238 citations

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

Thomas Seck, Michael A. Nauck, Sheila Sunga et al. · International Journal of Clinical Practice · 2010 · 202 citations

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

, , +11

Rows per page

1–5 of 79